GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Iran Daru (XTEH:IRDR1) » Definitions » Price-to-Owner-Earnings

Iran Daru (XTEH:IRDR1) Price-to-Owner-Earnings : (As of Jun. 14, 2024)


View and export this data going back to 1990. Start your Free Trial

What is Iran Daru Price-to-Owner-Earnings?

As of today (2024-06-14), Iran Daru's share price is IRR12710.00. Iran Daru does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Iran Daru's Price-to-Owner-Earnings or its related term are showing as below:


XTEH:IRDR1's Price-to-Owner-Earnings is not ranked *
in the Drug Manufacturers industry.
Industry Median: 25.01
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-14), Iran Daru's share price is IRR12710.00. Iran Daru does not have enough years/quarters to calculate the Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in . 20. Therefore GuruFocus does not calculate PE Ratio at this moment.

As of today (2024-06-14), Iran Daru's share price is IRR12710.00. Iran Daru does not have enough years/quarters to calculate the EPS without NRI for the trailing twelve months (TTM) ended in . 20. Therefore GuruFocus does not calculate PE Ratio without NRI at this moment.


Iran Daru Price-to-Owner-Earnings Historical Data

The historical data trend for Iran Daru's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Iran Daru Price-to-Owner-Earnings Chart

Iran Daru Annual Data
Trend
Price-to-Owner-Earnings

Iran Daru Semi-Annual Data
Price-to-Owner-Earnings

Competitive Comparison of Iran Daru's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Iran Daru's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Iran Daru's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Iran Daru's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Iran Daru's Price-to-Owner-Earnings falls into.



Iran Daru Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Iran Daru's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=12710.00/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Iran Daru  (XTEH:IRDR1) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Iran Daru Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Iran Daru's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Iran Daru (XTEH:IRDR1) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Ayatollah Saeedi Highway, End Of Kermani Street, Moallem Boulevard, Tehran, IRN, 1371658111
Iran Daru is a pharmaceutical company based in Iran. It manufactures and sells pharmaceutical products for antibiotics, cardiovascular agents, and local anesthetic agents. The company manufactures products in three main dosage form categories namely solid, semi-solid, and liquid including tablets, capsules, pellets, sachets, gels, creams, ointments (sterile and non-sterile), spray solutions, and syrups. Products offered by Iran Daru include Diclofenac Potassium, Biotin 5 mg, Tetracycline, Folic acid, Meloxicam, Acetaminophen and Caffeine, and Levocetirizine dihydrochloride, among others. It also exports its products to other countries.

Iran Daru (XTEH:IRDR1) Headlines

No Headlines